Literature DB >> 11350866

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

D J Naisbitt1, S F Gordon, M Pirmohamed, C Burkhart, A E Cribb, W J Pichler, B K Park.   

Abstract

Sulphamethoxazole has been associated with the occurrence of hypersensitivity reactions. There is controversy as to whether the immune response is metabolism-dependent or -independent. We have therefore investigated the site of antigen formation and the nature of the drug signal presented to the immune system in vivo. Male Wistar rats were dosed with sulphamethoxazole, sulphamethoxazole hydroxylamine or nitroso sulphamethoxazole. Antigen formation on cell surfaces was determined by flow cytometry using a specific anti-sulphamethoxazole antibody. Immunogenicity was determined by assessment of ex vivo T-cell proliferation. Administration of nitroso sulphamethoxazole, but not sulphamethoxazole or sulphamethoxazole hydroxylamine, resulted in antigen formation on the surface of lymphocytes, splenocytes and epidermal keratinocytes, and a strong proliferative response of splenocytes on re-stimulation with nitroso sulphamethoxazole. Rats dosed with sulphamethoxazole or sulphamethoxazole hydroxylamine did not respond to any of the test compounds. CD4+ or CD8+ depleted cells responded equally to nitroso sulphamethoxazole. The proliferative response to nitroso sulphamethoxazole was seen even after pulsing for only 5 min, and was not inhibited by glutathione. Responding cells produced IFN-gamma, but not IL-4. Haptenation of cells by sulphamethoxazole hydroxylamine was seen after depletion of glutathione by pre-treating the rats with diethyl maleate. Splenocytes from the glutathione-depleted sulphamethoxazole hydroxylamine-treated rats responded weakly to nitroso sulphamethoxazole, but not to sulphamethoxazole or sulphamethoxazole hydroxylamine. Dosing of rats with sulphamethoxazole produced a cellular response to nitroso sulphamethoxazole (but not to sulphamethoxazole or its hydroxylamine) when the animals were primed with complete Freund's adjuvant. These studies demonstrate the antigenicity of nitroso sulphamethoxazole in vivo and provide evidence for the role of drug metabolism and cell surface haptenation in the induction of a cellular immune response in the rat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350866      PMCID: PMC1572782          DOI: 10.1038/sj.bjp.0704074

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  56 in total

Review 1.  General and epidemiological aspects of allergic drug reactions.

Authors:  P Barranco; M C López-Serrano
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

Review 2.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

3.  Mechanisms of drug allergy.

Authors:  J W Coleman; M Blanca
Journal:  Immunol Today       Date:  1998-05

Review 4.  Adjuvants in perspective.

Authors:  F R Vogel
Journal:  Dev Biol Stand       Date:  1998

5.  Contact sensitivity in the pig. II. Induction by intralymphatic infusion of DNP conjugated cells.

Authors:  B Søeberg; T Sumerska; R M Binns; B M Balfour
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

6.  Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones.

Authors:  S von Greyerz; M P Zanni; K Frutig; B Schnyder; C Burkhart; W J Pichler
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

7.  HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.

Authors:  M P Zanni; S von Greyerz; B Schnyder; K A Brander; K Frutig; Y Hari; S Valitutti; W J Pichler
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

8.  Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.

Authors:  Y Suzuki; R Inagi; T Aono; K Yamanishi; T Shiohara
Journal:  Arch Dermatol       Date:  1998-09

9.  Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.

Authors:  M Tohyama; Y Yahata; M Yasukawa; R Inagi; Y Urano; K Yamanishi; K Hashimoto
Journal:  Arch Dermatol       Date:  1998-09

Review 10.  Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity.

Authors:  R S Kalish; P W Askenase
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

View more
  24 in total

1.  The impact of pharmacogenetics in the treatment of allergic disease and asthma.

Authors:  Bridgette L Jones
Journal:  Mo Med       Date:  2011 Sep-Oct

Review 2.  [Pharmacogenetics].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

Review 3.  Role of bioactivation in drug-induced hypersensitivity reactions.

Authors:  Joseph P Sanderson; Dean J Naisbitt; B Kevin Park
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

4.  Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.

Authors:  Mahmoud Abouraya; James C Sacco; Brad S Kahl; Lauren A Trepanier
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

5.  Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.

Authors:  Ayman Elsheikh; Sidonie N Lavergne; J Luis Castrejon; John Farrell; Haiyi Wang; Jean Sathish; Werner J Pichler; B Kevin Park; Dean J Naisbitt
Journal:  J Immunol       Date:  2010-10-27       Impact factor: 5.422

6.  "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.

Authors:  S N Lavergne; H Wang; H E Callan; B K Park; D J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2009-08-07       Impact factor: 4.030

7.  Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Authors:  Sachin Bhusari; Mahmoud Abouraya; Marcia L Padilla; Marie E Pinkerton; Nicholas J Drescher; James C Sacco; Lauren A Trepanier
Journal:  Arch Toxicol       Date:  2010-03-11       Impact factor: 5.153

Review 8.  T cells in drug allergy.

Authors:  Werner J Pichler
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

9.  Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.

Authors:  Yat Yee Wong; Eva G Rakasz; David J Gasper; Thomas C Friedrich; Lauren A Trepanier
Journal:  Toxicology       Date:  2016-08-23       Impact factor: 4.221

10.  Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.

Authors:  David J Feola; Beth A Garvy
Journal:  Clin Vaccine Immunol       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.